Literature DB >> 12678168

Comparative study of the effectiveness of zuclopenthixol acetate and haloperidol in acutely disturbed psychotic patients.

Unchulee Taymeeyapradit1, Surachai Kuasirikul.   

Abstract

OBJECTIVES: To study the effectiveness, frequency of administration and side effects of zuclopenthixol acetate (ZPTA) and haloperidol (HAL) in the treatment of acute psychotic disturbance with aggression.
METHOD: Purposive sampling method was employed in a group of psychotic patients with aggression admitted to Songkla Neuropsychiatric Hospital, they were randomly divided into 2 groups: ZPTA group and HAL group. All of the patients were evaluated daily for 7 consecutive days using the Brief Psychiatric Rating Scale (BPRS) and the Clinical Global Impression Scale (CGI). Statistical analysis was performed by using the Student t-test and Linear regression.
RESULTS: There were 70 patients with diagnosis of schizophrenia, mania and acute psychosis. Thirty-eight patients were randomly assigned to the ZPTA group and were given 50-100 mg of the drug, while 32 patients received HAL 5-10 mg. The result showed a significant reduction in BPRS or CGI scores in both groups. Patients treated with ZPTA required less frequent administration than did those on HAL (p < 0.05). There was no statistically significant difference in the reduction in scores between the two groups. Nor was there a statistical difference in reduction of aggression based on BPRS rating. Each group of patients showed a few side effects of mild degree.
CONCLUSION: Both ZPTA and HAL were effective in the treatment of acute psychosis with aggression, but frequency of administration was lower in the ZPTA group

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12678168

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  4 in total

Review 1.  Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).

Authors:  Edoardo G Ostinelli; Melanie J Brooke-Powney; Xue Li; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

Review 2.  Zuclopenthixol dihydrochloride for schizophrenia.

Authors:  Edward J Bryan; Marie Ann Purcell; Ajit Kumar
Journal:  Cochrane Database Syst Rev       Date:  2017-11-16

Review 3.  Pharmacological management of acute agitation.

Authors:  John Battaglia
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.

Authors:  Kaushadh Jayakody; Roger Carl Gibson; Ajit Kumar; Shalmini Gunadasa
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.